These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16209015)

  • 21. [The strategy for curing open pulmonary tuberculosis in a short period].
    Ursov IG
    Ter Arkh; 1993; 65(11):36-9. PubMed ID: 8108794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antituberculosis antibodies in patients with tuberculosis during chemotherapy].
    Stakhanov VA; Vasil'ev NA; Levi DT; Rukhamina ML
    Probl Tuberk; 2001; (5):48-50. PubMed ID: 11588965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recovery criteria and time in patients with pulmonary tuberculosis].
    Gavrilenko VS
    Probl Tuberk; 2001; (8):10-4. PubMed ID: 11767380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M; Nakajima Y
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficiency of a hospital stage of complex treatment in adult patients with pulmonary tuberculosis].
    Aminev KhK; Azamatova MM; Giliazitdinov KA; Fattakhova LZ; Gol'ianova KI; Toptsiĭ VG
    Probl Tuberk Bolezn Legk; 2007; (6):4-9. PubMed ID: 17672054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Variants of the involution of pulmonary tuberculosis].
    Modelevskiĭ BS
    Probl Tuberk; 1992; (5-6):18-20. PubMed ID: 1409506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with treatment success for tuberculosis patients: a single center's experience in Turkey.
    Talay F; Kumbetli S; Altin S
    Jpn J Infect Dis; 2008 Jan; 61(1):25-30. PubMed ID: 18219130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical efficiency of combined chemotherapy of patients with progressive forms of pulmonary tuberculosis].
    Cheren'ko SO
    Lik Sprava; 2001; (1):76-80. PubMed ID: 15311700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative characterization of molecular and microbiological methods for controlling chemotherapy in new cases of pulmonary tuberculosis].
    Larionova EE; Kuz'min AV; Vavil'eva IA; Chernousova LN; Golyshevskaia VI
    Probl Tuberk Bolezn Legk; 2004; (6):31-4. PubMed ID: 15315129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM; Iarygina IV
    Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of the immediate results of intensive short-term antitubercular chemotherapy with those of the classic regimens lasting 9 months].
    Cioflec D; Boariu I; Dumitru V; Bobic A; Mihalache F; Mihalache D; Constantinescu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):261-8. PubMed ID: 2855672
    [No Abstract]   [Full Text] [Related]  

  • 35. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
    Gergert VIa; Rusakova LI
    Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA; Skvortsova LA; Pavlova MV; Sapozhnikova NV; Archakova LI; Vishnevskiĭ BI
    Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of active detection and treatment of patients with tuberculosis on fatal outcomes].
    Glumnaia TV
    Probl Tuberk Bolezn Legk; 2006; (7):22-7. PubMed ID: 16944709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of the abnormal tracheobroncheal tree in the efficiency of treatment of patients with pulmonary tuberculosis].
    Maliev BM; Gracheva MP; Beliaev DL; Gabaraev AS
    Probl Tuberk Bolezn Legk; 2007; (8):19-25. PubMed ID: 17915462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV; Vasil'eva IA; Chernousova LN
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.